Openbookopenbook
Equity
Biogaia AB ADR(BIOGY)
USD --+0.00%
Reward55Moderate
Risk13Low
📊75%Data
Strong 22% profit margin · Revenue growing 21% YoY
BIOGY
+0.0 · +0.00%
USD · PINK
Biogaia AB ADR | Healthcare
Quality Compounder
Market Cap:990.38M
ℹ️
Reward Rating
55
Moderate
Bottom 50% (model universe)
75% data coverage
ℹ️
Risk Rating
13
Low
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on BIOGY to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Biogaia AB ADR?

BioGaia AB (publ), a healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.

BIOGY · Verdict

Solid reward · low risk

BIOGY stands out on cash flow and volatility, but watch the valuation signal.

Based on 88% data coverage

BIOGY · Verdict

What’s working & what to watch

Strengths 4

  • Cash flow95/100

    20% free-cash-flow margin

  • Volatility95/100

    Top decile vs peers

  • Balance sheet85/100

    Interest covered 50.9×

  • Profitability82/100

    22% net margin · 22% ROE

Watchouts 1

  • Valuation43/100

    Below average

Model-based scoring. For information only — not financial advice.

What is Biogaia AB ADR?

BioGaia AB (publ), a healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand. It operates through Pediatrics, Adult Health, and Other segments. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 990.38M, and a P/E ratio of 28.0x.

Financial Highlights

Investment Breakdown

📈 Growth
Revenue and earnings growing steadily, indicating improving operating performance.
💰 Profitability
Strong margins and consistent earnings support financial stability.
⚠️ Risk
Below-average volatility supports a steadier risk profile.
💸 Valuation
Valuation appears fair relative to current fundamentals.

OpenBook Logo Analysis

Reward: Moderate (55)

The scoring profile indicates moderate reward potential, with profitability and momentum as the leading contributors. Risk indicators are low, suggesting a relatively contained downside profile.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap990.38M
P/E Ratio27.9714
Dividend YieldN/A
52 Week High11.46
52 Week Low8.79
Last AnnualDecember
IPO DateN/A
IncorporatedUSA
Shares Outstanding98M
No. of Employees242
IndustryDrug Manufacturers - Specialty & Generic
ExchangePINK
Beta0.32
CurrencyUSD · Reports in SEK
Websitewww.biogaiagroup.com
openbook

Stock research for everyday UK investors. Make smarter decisions, faster.

Questions? Email us at contact@openbookanalytics.com

© 2026 Openbook Analytics Ltd · Company No. SC843579 · Registered in Scotland

256-bit encryption GDPR compliant UK data centres

Openbook Analytics Ltd (Company No. SC843579) is registered in Scotland. Registered office: Strathclyde Inspire Hub, University of Strathclyde, Graham Hills Building (Level 6), 50 Richmond Street, Glasgow, G1 1XP. Openbook Analytics is not authorised or regulated by the Financial Conduct Authority (FCA). The content on this platform is provided for general informational and educational purposes only and does not constitute financial advice, investment advice, trading advice, or any other form of advice. You should not treat any content on this platform as a recommendation to buy, sell, or hold any financial instrument. Past performance is not a reliable indicator of future results. The value of investments and the income from them can go down as well as up, and you may get back less than you invest. User-generated content, including community posts and commentary, reflects the personal opinions of individual users, is not verified for accuracy, and does not represent the views of Openbook Analytics Ltd. You should always conduct your own research or consult a qualified, FCA-regulated financial adviser before making investment decisions. Data displayed on this platform may be delayed or inaccurate and is provided "as is" without warranty. Openbook Analytics Ltd accepts no liability for any loss arising from reliance on the information provided.